Data Conversion Laboratory, Court Square Group, and JANA Life Sciences Launch Learning Series to Inform Technology and Intelligent Content Solutions to the Life Sciences Market

Fresh Meadows, NY, November 19, 2020 – Data Conversion Laboratory (DCL), Court Square Group, and JANA Life Sciences announce a learning series for life sciences and biomedical research organizations to dive deep into content structure and cloud-based solutions for managing and safeguarding content in the life sciences. A series of webinars beginning December 10 and continuing into 2021 provide life science organizations with a rich understanding of technology considerations related to content and data.

​

Technology plays a critical role in the life sciences where accuracy, traceability, and compliance along with speed-to-market is critical. Improving content and data management, IT systems, compliance, and program management streamlines research, drug development, and the regulatory approval process. These leading technology firms have a deep history of content and data structure expertise, FDA 21 CFR Part11 compliant infrastructure and tools, and technical documentation capabilities that support success at every stage of the pharma and biomedical product life cycle.

​

“The goal of this webinar series is to inform life science organizations about technology considerations related to content and data,” explains Mark Gross, President of DCL. “Intelligent content solutions and cloud-based solutions applied to the drug development life cycle improve downstream communication and speed up the approval process, ultimately bringing scientific breakthroughs to market both quickly and safely.”

​

DCL provides content structure to documents that are critical to support the life sciences industry. With the latest advances in artificial intelligence and natural language processing, DCL’s content enrichment services improve content discovery for R&D applications during the development of new drugs or reclassification of pharma agents. Additionally, DCL’s structured product labeling (SPL) work comprises deconstructing forms-based content and image-based PDFs to create structured markup (XML). DCL creates and delivers final SPL files to the FDA on behalf of its clients.

​

Technology is critical to improving how the biomedical and pharma industries can increase business performance while also securing intellectual property. DCL, Court Square Group, and JANA Life Sciences provide technology solutions that support pharma and biotech companies and ensure regulatory compliance, ultimately bringing products to market faster.